Observational studyJournal of endocrinological investigation2026

Risk factors for endocrinological immune-related adverse events in patients with renal cell carcinoma treated with immune checkpoint inhibitors.

Nicola Marrano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.